Actavis, Inc. (ACT) SEC Filing 8-K Material Event for the period ending Tuesday, October 29, 2013

Actavis, Inc.

CIK: 884629

View differences made from one to another to evaluate Actavis, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Actavis, Inc..


Assess how Actavis, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Actavis, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 884629
Form Type: 8-K Corporate News
Accession Number: 0001193125-13-414339
Submitted to the SEC: Tue Oct 29 2013 7:30:59 AM EST
Accepted by the SEC: Tue Oct 29 2013
Period: Tuesday, October 29, 2013
Industry: Pharmaceutical Preparations
  1. Earnings Release
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: